Cargando…

Morphological profiling of tubercle bacilli identifies drug pathways of action

Morphological profiling is a method to classify target pathways of antibacterials based on how bacteria respond to treatment through changes to cellular shape and spatial organization. Here we utilized the cell-to-cell variation in morphological features of Mycobacterium tuberculosis bacilli to deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Trever C., Pullen, Krista M., Olson, Michaela C., McNellis, Morgan E., Richardson, Ian, Hu, Sophia, Larkins-Ford, Jonah, Wang, Xin, Freundlich, Joel S., Ando, D. Michael, Aldridge, Bree B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414088/
https://www.ncbi.nlm.nih.gov/pubmed/32680963
http://dx.doi.org/10.1073/pnas.2002738117
_version_ 1783568908508200960
author Smith, Trever C.
Pullen, Krista M.
Olson, Michaela C.
McNellis, Morgan E.
Richardson, Ian
Hu, Sophia
Larkins-Ford, Jonah
Wang, Xin
Freundlich, Joel S.
Ando, D. Michael
Aldridge, Bree B.
author_facet Smith, Trever C.
Pullen, Krista M.
Olson, Michaela C.
McNellis, Morgan E.
Richardson, Ian
Hu, Sophia
Larkins-Ford, Jonah
Wang, Xin
Freundlich, Joel S.
Ando, D. Michael
Aldridge, Bree B.
author_sort Smith, Trever C.
collection PubMed
description Morphological profiling is a method to classify target pathways of antibacterials based on how bacteria respond to treatment through changes to cellular shape and spatial organization. Here we utilized the cell-to-cell variation in morphological features of Mycobacterium tuberculosis bacilli to develop a rapid profiling platform called Morphological Evaluation and Understanding of Stress (MorphEUS). MorphEUS classified 94% of tested drugs correctly into broad categories according to modes of action previously identified in the literature. In the other 6%, MorphEUS pointed to key off-target activities. We observed cell wall damage induced by bedaquiline and moxifloxacin through secondary effects downstream from their main target pathways. We implemented MorphEUS to correctly classify three compounds in a blinded study and identified an off-target effect for one compound that was not readily apparent in previous studies. We anticipate that the ability of MorphEUS to rapidly identify pathways of drug action and the proximal cause of cellular damage in tubercle bacilli will make it applicable to other pathogens and cell types where morphological responses are subtle and heterogeneous.
format Online
Article
Text
id pubmed-7414088
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-74140882020-08-21 Morphological profiling of tubercle bacilli identifies drug pathways of action Smith, Trever C. Pullen, Krista M. Olson, Michaela C. McNellis, Morgan E. Richardson, Ian Hu, Sophia Larkins-Ford, Jonah Wang, Xin Freundlich, Joel S. Ando, D. Michael Aldridge, Bree B. Proc Natl Acad Sci U S A Biological Sciences Morphological profiling is a method to classify target pathways of antibacterials based on how bacteria respond to treatment through changes to cellular shape and spatial organization. Here we utilized the cell-to-cell variation in morphological features of Mycobacterium tuberculosis bacilli to develop a rapid profiling platform called Morphological Evaluation and Understanding of Stress (MorphEUS). MorphEUS classified 94% of tested drugs correctly into broad categories according to modes of action previously identified in the literature. In the other 6%, MorphEUS pointed to key off-target activities. We observed cell wall damage induced by bedaquiline and moxifloxacin through secondary effects downstream from their main target pathways. We implemented MorphEUS to correctly classify three compounds in a blinded study and identified an off-target effect for one compound that was not readily apparent in previous studies. We anticipate that the ability of MorphEUS to rapidly identify pathways of drug action and the proximal cause of cellular damage in tubercle bacilli will make it applicable to other pathogens and cell types where morphological responses are subtle and heterogeneous. National Academy of Sciences 2020-08-04 2020-07-17 /pmc/articles/PMC7414088/ /pubmed/32680963 http://dx.doi.org/10.1073/pnas.2002738117 Text en Copyright © 2020 the Author(s). Published by PNAS. http://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Biological Sciences
Smith, Trever C.
Pullen, Krista M.
Olson, Michaela C.
McNellis, Morgan E.
Richardson, Ian
Hu, Sophia
Larkins-Ford, Jonah
Wang, Xin
Freundlich, Joel S.
Ando, D. Michael
Aldridge, Bree B.
Morphological profiling of tubercle bacilli identifies drug pathways of action
title Morphological profiling of tubercle bacilli identifies drug pathways of action
title_full Morphological profiling of tubercle bacilli identifies drug pathways of action
title_fullStr Morphological profiling of tubercle bacilli identifies drug pathways of action
title_full_unstemmed Morphological profiling of tubercle bacilli identifies drug pathways of action
title_short Morphological profiling of tubercle bacilli identifies drug pathways of action
title_sort morphological profiling of tubercle bacilli identifies drug pathways of action
topic Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414088/
https://www.ncbi.nlm.nih.gov/pubmed/32680963
http://dx.doi.org/10.1073/pnas.2002738117
work_keys_str_mv AT smithtreverc morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction
AT pullenkristam morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction
AT olsonmichaelac morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction
AT mcnellismorgane morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction
AT richardsonian morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction
AT husophia morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction
AT larkinsfordjonah morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction
AT wangxin morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction
AT freundlichjoels morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction
AT andodmichael morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction
AT aldridgebreeb morphologicalprofilingoftuberclebacilliidentifiesdrugpathwaysofaction